Stock SSII SS INNOVATIONS INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SS Innovations International, Inc.

Equities

SSII

US05453U2033

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 20:51:14 10/05/2024 BST 		5-day change 1st Jan Change
4.25 USD 0.00% Intraday chart for SS Innovations International, Inc. -5.56% -41.38%
04-29 SS Innovations International, Inc. Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System CI
04-10 SS Innovations International, Inc.?s SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures CI

Valuation

Fiscal Period: December 2023
Capitalization 1 1,238
Enterprise Value (EV) 1 1,244
P/E ratio -44.5 x
Yield -
Capitalization / Revenue 210 x
EV / Revenue 212 x
EV / EBITDA -60.7 x
EV / FCF -108,228,504 x
FCF Yield -0%
Price to Book 86.6 x
Nbr of stocks (in thousands) 170,712
Reference price 2 7.250
Announcement Date 22/03/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 2.841 1.458 5.88
EBITDA 1 -0.3377 -3.274 -20.51
EBIT 1 -0.4247 -3.394 -20.67
Operating Margin -14.95% -232.71% -351.52%
Earnings before Tax (EBT) 1 -0.4235 -3.388 -20.94
Net income 1 -0.4235 -3.388 -20.94
Net margin -14.9% -232.36% -356.17%
EPS 2 -0.1482 - -0.1630
Free Cash Flow - -2.579 -11.49
FCF margin - -176.82% -195.47%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 26/06/23 26/06/23 22/03/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 0.63 6.03 6.2
Net Cash position 1 - - -
Leverage (Debt/EBITDA) -1.878 x -1.841 x -0.3022 x
Free Cash Flow - -2.58 -11.5
ROE (net income / shareholders' equity) - 317% -354%
ROA (Net income/ Total Assets) - -70.1% -75.6%
Assets 1 - 4.834 27.69
Book Value Per Share 2 0.2200 - 0.0800
Cash Flow per Share 2 0.0100 - 0.0100
Capex 1 0.04 0.22 2.76
Capex / Sales 1.37% 15.11% 47%
Announcement Date 26/06/23 26/06/23 22/03/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SS INNOVATIONS INTERNATIONAL, INC. Stock SS Innovations International, Inc.
-41.38% 726M
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SSII Stock
  4. Financials SS Innovations International, Inc.